Two days left to actively participate in acadia pharmaceuticals inc. (acad) class action: bronstein, gewirtz & grossman, llc

New york--(business wire)--attorney advertising--bronstein, gewirtz & grossman, llc notifies investors that a class action lawsuit has been filed against acadia pharmaceuticals inc. ("acadia" or "the company") (nasdaq: acad) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired acadia securities between june 15, 2020 and april 4, 2021, both dates inclusive (the "class period"). such investors are encouraged to join this case by visiting the firm's site:
ACAD Ratings Summary
ACAD Quant Ranking